This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 Mar;47(2):161-162.

doi: 10.1111/ceo.13473.

Myopic choroidal neovascularization: To load or not to load

Elisa E Cornish¹, Mark C Gillies¹

Affiliations

PMID: 30892793
DOI: 10.1111/ceo.13473

Editorial

Myopic choroidal neovascularization: To load or not to load

Elisa E Cornish et al. Clin Exp Ophthalmol. 2019 Mar.

. 2019 Mar;47(2):161-162.

doi: 10.1111/ceo.13473.

Authors

Elisa E Cornish¹, Mark C Gillies¹

Affiliation

¹ Save Sight Institute, University of Sydney and Sydney Eye Hospital, Sydney, Australia.

PMID: 30892793
DOI: 10.1111/ceo.13473

No abstract available

PubMed Disclaimer

Comment on

Two different initial treatment regimens of ranibizumab in myopic choroidal neovascularization: 12-month results from a randomized controlled study.
Li S, Ding X, Sun L, Zhao X, Zhang A, Lyu C, Liu B, Zhang J, Jin C, Lu L. Li S, et al. Clin Exp Ophthalmol. 2019 Mar;47(2):250-258. doi: 10.1111/ceo.13424. Epub 2018 Nov 22. Clin Exp Ophthalmol. 2019. PMID: 30345611 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Wiley